Long-Term Oral Acyclovir Usage to Prevent Herpes Zoster Virus Infection After Bone Marrow Transplant
Randomized Trial of Long-Term Oral Acyclovir Usage to Prevent Varicella Zoster Virus Infection After Allogeneic Bone Marrow Transplant
Randomized Trial of Long-Term Oral Acyclovir Usage to Prevent Varicella Zoster Virus Infection After Allogeneic Bone Marrow Transplant
Sponsor study identifier
Secondary identifiers
interventional
120
1 country
1
Study Start
June 1985
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
Not reported
Date not reportedStudy Completion
July 2004
Actual (reported)The objective of this study is to prevent reactivation of herpes zoster during the first year after transplant.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
July 2004
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
June 1985
Date type not reportedThis date has not been verified as actual or estimated.
July 2004
Actual (reported)September 13, 2005
Actual (reported)September 21, 2005
Actual (reported)VZV infection at one year
VZV infection after discontinuation of prophylaxis
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Fred Hutchinson Cancer Research Center
Seattle, Washington, 98109, United States
Boeckh M, Kim HW, Flowers ME, Meyers JD, Bowden RA. Long-term acyclovir for prevention of varicella zoster virus disease after allogeneic hematopoietic cell transplantation--a randomized double-blind placebo-controlled study. Blood. 2006 Mar 1;107(5):1800-5. doi: 10.1182/blood-2005-09-3624. Epub 2005 Nov 10.
Michael Boeckh, MD
Fred Hutchinson Cancer Center
First Submitted
September 13, 2005
First Posted
September 21, 2005
Study Start
June 1985
Date type not reportedThis date has not been verified as actual or estimated.
Study Completion
July 2004
Actual (reported)Phase III Randomized Study of Oral Acyclovir in Infants With Herpes Simplex Virus Infection Limited to Skin, Eyes, and Mouth
Contact the study team to confirm eligibility.
Last Updated
December 21, 2007
Record last verified: 2007-12
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: